astrazeneca glp 1 pipeline Current and incretin portfolio: GLP‑1, GLP‑1/GIP, GLP‑1/GRA, and amylin‑containing combinations across SC and oral routes, with several Phase 2–3 agents aiming for ~20–25% weight loss and cardiometabolic indications. https://t.co/PHnJAIbM2G Current and pipeline incretin portfolio:

In under-resourced parts of Los Angeles, people develop life-altering, preventable diabetes complications related to obesity

Through differentiated development strategies and novel mechanisms that address unmet needs in obesity treatment, Hanmi is committed to becoming a global leader in obesity innovation

Weight loss injection Ozempic now available from Click2Pharmacy's UK Online Clinic

These blockbuster weight-loss drugs could unlock future discoveries for a range of interlinked chronic diseases.

In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...

We benchmarked the GLP-1RA age-counteracting effects against those of mTOR inhibition, a well-estab...